[HTML] spandidos-publications.com

[HTML][HTML] Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2019 - spandidos-publications.com
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …
被引用次数：18 相关文章

Intranasal instillation of miR-410 targeting IL-4/IL-13 attenuates airway inflammation in OVA-induced asthmatic mice

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2019 - search.proquest.com
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …
[HTML] nih.gov

[HTML][HTML] Intranasal instillation of miR-410 targeting IL-4/IL-13 attenuates airway inflammation in OVA-induced asthmatic mice

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2019 - ncbi.nlm.nih.gov
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …
[HTML] spandidos-publications.com

[HTML][HTML] Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2019 - spandidos-publications.com
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …

Intranasal instillation of miR-410 targeting IL-4/IL-13 attenuates airway inflammation in OVA-induced asthmatic mice

R Jin, S Hu, X Liu, R Guan, L Lu, R Lin - Molecular Medicine Reports, 2019 - go.gale.com
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …

Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice.

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2018 - europepmc.org
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …

Intranasal instillation of miR-410 targeting IL-4/IL-13 attenuates airway inflammation in OVA-induced asthmatic mice.

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2019 - search.ebscohost.com
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …
[PDF] semanticscholar.org

[PDF][PDF] Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice

R JIN, S HU, X LIU, R GUAN… - MOLECULAR …, 2019 - pdfs.semanticscholar.org
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …

Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular medicine …, 2019 - pubmed.ncbi.nlm.nih.gov
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …

Intranasal instillation of miR‑410 targeting IL‑4/IL‑13 attenuates airway inflammation in OVA‑induced asthmatic mice.

R Jin, S Hu, X Liu, R Guan, L Lu… - Molecular Medicine …, 2018 - europepmc.org
Asthma is a common chronic inflammatory respiratory disease characterised by airway
inflammation and hyperresponsiveness. The present study was designed to clarify the effect …